Since December, the Albany International Airport has been offering covid testing to all travellers and staff at the airport. The test, called the Clarifi COVID-19 Test Kit, was co-developed by Quadrant Biosciences and SUNY Upstate Medical University in Syracuse, and has been used to test over a half million students and faculty at SUNY colleges

Quadrant Biosciences and SUNY Upstate Medical University have been chosen as recipients of MedTech’s 2020 Project of the Year award for the development of the Clarifi COVID-19 saliva test. The award recognizes an initiative that has had a “singular and demonstrable positive impact on public health.” The Clarifi COVID-19 saliva test was co-developed by Quadrant

This past December, the United States Food and Drug Administration (FDA) ranked the Clarifi COVID-19 Test Kit as the most sensitive COVID-19 saliva test currently available on the market.  In a statement released by the office of Governor Andrew Cuomo, the Governor congratulated Quadrant Biosciences and SUNY Upstate Medical for our work developing the Clarifi

Over the past six months, Quadrant Biosciences has been working in collaboration with New York State to develop and implement several COVID-19 detection projects. These include a program to detect the SARS-CoV-2 RNA virus in wastewater, and a pooled testing program for New York colleges.  In a recent press release, Governor Cuomo announced these new

Could saliva be the key to concussion diagnosis and management?  Scientists say yes, according to the study “Diagnosing Mild Traumatic Brain Injury Using Saliva RNA Compared to Cognitive and Balance Testing,” published in Clinical and Translational Medicine. Researchers from Quadrant Biosciences, Penn State College of Medicine, SUNY Buffalo Jacobs School of Medicine, and SUNY Medical

Quadrant Biosciences is excited to share that Dr. Thomas Frazier II, PhD, will be joining our clinical advisory board. Dr Frazier is currently a Professor of Psychology at John Carroll University one of the leading researchers in the field of autism.  Dr. Frazier has been a prominent figure in the field of autism research for

We’re excited to share a new opportunity for investors looking to help improve the lives of  families across the country.  Quadrant Biosciences is now offering common shares to the general public through the equity crowdfunding platform, Wefunder.  This campaign is the first time Quadrant is offering shares to the public at large, however we’ve previously

Last week, we had the great privilege of being invited back on Autism Live. During the webshow, we were able to discuss the recent launch of our autism saliva test, Clarifi ASD (some of you may recall our segment on the show last spring). Autism Live is an interactive web show hosted by Shannon Penrod,

With the continued spread of COVID-19, families everywhere are taking precautions to stay healthy. But for families who have a child with autism, some of those precautions, like social distancing for example, may be especially stressful.  So we thought it would be helpful to compile some tips and links to resources from various autism and

An update from the CEO, Rich Uhlig. I hope everyone is staying safe in these tumultuous times. I wanted to update you on my recent visit to Washington D.C. to engage with key members of Congress and the Executive Branch about our autism saliva test, Clarifi ASD. My colleagues from Quadrant and I had the

Quadrant Biosciences Awarded Grant for Autism Research We’re excited to share that our company, Quadrant Biosciences, has been awarded a $330,000 grant from the National Institutes of Health (NIH).  This grant will support the next phase in our autism research. Previously, the NIH awarded us a $2 million  Phase II Small Business Technology Transfer (STTR)

New research has recently emerged that “changes in the bacteria within a child’s mouth may provide biomarkers for identifying autism.”[1]  This technology is being developed into a saliva test which will aid clinicians in autism diagnosis. Previous research has established the presence of a disrupted gut-brain signaling in children with autism spectrum disorder (ASD). [2]

Have you visited our website recently? If so, you’ve seen some significant changes in the look of our site.  Since our company’s inception over 5 years ago, our mission has been to find biological solutions for important neurological health issues.  At first, this stemmed from our Founder and CEO Rich Uhlig’s desire to have better

Quadrant Biosciences Wins New York Technology Award We’re excited to share that our company, Quadrant Biosciences, has been recognized as the New York Technology Business of the Year for our breakthrough epigenetic research! The award, presented by the New York State Small Business Development Center (SBDC),  recognizes the boldest, brightest, and best small companies in

This past weekend, baseball fans all around Syracuse, NY were able to watch their local Mets play live, without the sensory overload. We were happy to be able to bring Autism Awareness Day back to our community, with the help of our partners at Upstate Medical University. With autistic baseball fans in mind, the game

Increasingly, more research is being published globally supporting the gut-brain connection theory and the important role of epigenetics and the microbiome in relation to autism spectrum disorder (ASD). In 2018, scientists discovered that certain molecules in the saliva, called non-coding RNAs, not only differentiate children with ASD, but appear to correlate with specific autism traits.

Supporting Our Community This past November, Quadrant Biosciences had the opportunity to visit the AAP (American Academy of Pediatrics) Conference in Orlando, FL. We were so excited to unveil our autism saliva test to thousands of pediatricians from across the world, that we brought some extra goodies, too… But the biggest hit were our custom